Accéder au contenu
MilliporeSigma

Principaux documents

Voir toute la documentation

Passer à

605492

Sigma-Aldrich

D-Mannitol-13C6

99 atom % 13C, 99% (CP)

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme

About This Item

Formule linéaire :
HO13CH2[13CH(OH)]413CH2OH
Poids moléculaire :
188.13
Numéro MDL:
MFCD01075541
Code UNSPSC :
12352001
ID de substance PubChem :
329759062
Note: This product can be packaged on demand. For information on pricing, availability and packaging of custom sizes, please contact Stable Isotopes Customer Service

Pureté isotopique

99 atom % 13C

Essai

99% (CP)

Forme

solid

Activité optique

[α]25/D +141°, c = 0.4 in acidified ammonium molybdate

Pf

167-170 °C (lit.)

Changement de masse

M+6

Chaîne SMILES 

O[13CH2][13C@@H](O)[13C@@H](O)[13C@H](O)[13C@H](O)[13CH2]O

InChI

1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4-,5-,6-/m1/s1/i1+1,2+1,3+1,4+1,5+1,6+1

Clé InChI

FBPFZTCFMRRESA-CRWJSTOYSA-N

Catégories apparentées

Comparer avec des articles similaires

Voir la comparaison complète

Montrer les différences

1 of 4

Cet article
D6196C5976A8106
Indinavir sulfate salt hydrate ≥98% (HPLC)

SML0189

Indinavir sulfate salt hydrate

Dimebon dihydrochloride hydrate ≥98% (HPLC)

D6196

Dimebon dihydrochloride hydrate

CL 316,243 hydrate ≥98% (HPLC), powder

C5976

CL 316,243 hydrate

Altanserin hydrochloride hydrate ≥98% (HPLC), solid

A8106

Altanserin hydrochloride hydrate

form

powder

form

powder

form

powder

form

solid

assay

≥98% (HPLC)

assay

≥98% (HPLC)

assay

≥98% (HPLC)

assay

≥98% (HPLC)

Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

100

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

room temp

storage temp.

2-8°C

storage condition

desiccated

storage condition

-

storage condition

-

storage condition

-

solubility

H2O: ≥15 mg/mL

solubility

H2O: ≥10 mg/mL

solubility

H2O: 10 mg/mL, clear

solubility

DMSO: >5 mg/mL, H2O: insoluble

Conditionnement

This product may be available from bulk stock and can be packaged on demand. For information on pricing, availability and packaging, please contact Stable Isotopes Customer Service.

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

    • Faites votre choix parmi les versions les plus récentes :

    Certificats d'analyse (COA)

    Lot/Batch Number
    MBBD3115
    MBBD2985
    MBBD2014
    MBBD1524
    MBBC9051

    Vous ne trouvez pas la bonne version ?

    Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.

    Rechercher un(e) COA

    Déjà en possession de ce produit ?

    Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

    Consulter la Bibliothèque de documents

    Les clients ont également consulté

    Slide 1 of 6

    1 of 6

    Busulfan analytical standard, for drug analysis

    Supelco

    B2635

    Busulfan

    Paclitaxel European Pharmacopoeia (EP) Reference Standard

    Y0000698

    Paclitaxel

    Paracetamol European Pharmacopoeia (EP) Reference Standard

    P0300000

    Paracetamol

    Cisplatin European Pharmacopoeia (EP) Reference Standard

    C2210000

    Cisplatin

    Cyclosporine Pharmaceutical Secondary Standard; Certified Reference Material

    Supelco

    PHR1092

    Cyclosporine

    Doxorubicin hydrochloride European Pharmacopoeia (EP) Reference Standard

    D2975000

    Doxorubicin hydrochloride

    Tanja Wenzler et al.
    Antimicrobial agents and chemotherapy, 58(8), 4452-4463 (2014-05-29)
    African sleeping sickness is a neglected tropical disease transmitted by tsetse flies. New and better drugs are still needed especially for its second stage, which is fatal if untreated. 28DAP010, a dipyridylbenzene analogue of DB829, is the second simple diamidine
    Shivaani Kummar et al.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 21(7), 1574-1582 (2015-01-16)
    Veliparib, a PARP inhibitor, demonstrated clinical activity in combination with oral cyclophosphamide in patients with BRCA-mutant solid tumors in a phase I trial. To define the relative contribution of PARP inhibition to the observed clinical activity, we conducted a randomized
    Gang Chen et al.
    Cancer immunology research, 2(10), 949-961 (2014-08-15)
    Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting tumor vaccines are bioactive, but limited by disease burden and immune tolerance. Cyclophosphamide augments vaccine activity in tolerant neu mice and in patients with metastatic breast cancer. HER2-specific monoclonal antibodies (mAb) enhance vaccine activity in neu
    Bridget P Keenan et al.
    Gastroenterology, 146(7), 1784-1794 (2014-03-13)
    Premalignant lesions and early stage tumors contain immunosuppressive microenvironments that create barriers for cancer vaccines. Kras(G12D/+);Trp53(R172H/+);Pdx-1-Cre (KPC) mice, which express an activated form of Kras in pancreatic tissues, develop pancreatic intraepithelial neoplasms (PanIN) that progress to pancreatic ductal adenocarcinoma (PDA).
    Sebastian Unizony et al.
    Arthritis & rheumatology (Hoboken, N.J.), 67(2), 535-544 (2014-10-22)
    CD5+ B cells have been conceptualized as a possible surrogate for Breg cells. The aim of the present study was to determine the utility of CD5+ B cells as biomarkers in antineutrophil cytoplasmic antibody-associated vasculitis (AAV). The absolute and relative
    Afficher tous les articles scientifiques apparentés

    Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

    Contacter notre Service technique